Main menu

NCM 2022: Rapid genomic analysis for thrombotic microangiopathy using nanopore adaptive sampling with EPI2ME SeqOne framework


Thrombotic microangiopathy (TMA) encompasses various genetically driven diseases. The highly repetitive character of sequences in this region makes it difficult to detect structural variants when using standard short-read sequencing methods. To implement a versatile, fast-track genomics analysis for TMA in adult renal disease at the Sorbonne University, ICU, we developed a framework using nanopore adaptive sampling coupled to the SeqOne platform for analysis. SeqOne provides a centralised cloud-based solution that includes a nanopore-validated pipeline derived from the EPI2ME framework. This new approach maximizes the chance of discovering new descriptions related to SNVs and SVs and could enable precision medicine for complement-mediated TMA in less than three days for targeted therapy.

Authors: Laurent Mesnard

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag